Aclarion Seeks Shareholder Approval for Significant Equity Plan Expansion, Authorizing 18.56% Potential Dilution

summarizeSummary

Aclarion, Inc. filed a definitive proxy statement for its annual meeting, seeking shareholder approval to significantly expand its 2022 Equity Incentive Plan, which could result in substantial future dilution.

check_boxKey Events

• Annual Meeting Scheduled

  The company will hold its Annual Meeting of Stockholders on June 4, 2026, to vote on several proposals.

• Significant Equity Plan Expansion Proposed

  Shareholders are asked to approve an amendment to the 2022 Equity Incentive Plan, increasing the total shares reserved for issuance by 457,026, from 42,974 to 500,000 shares.

• Substantial Potential Dilution

  If all newly authorized shares were issued, it would represent a potential dilution of approximately 18.56% to the current 2,462,250 outstanding shares.

• Increased Individual Grant Limits

  The annual per-participant grant limit for equity awards would be raised from 52 shares to 250,000 shares, providing significantly more flexibility for future grants.

auto_awesomeAnalysis

Aclarion, Inc. is seeking shareholder approval to substantially amend its 2022 Equity Incentive Plan. The proposed amendment would increase the total shares reserved for issuance by 457,026, bringing the new total to 500,000 shares. If all these newly authorized shares were issued, it would represent a potential dilution of approximately 18.56% to the current outstanding shares. Additionally, the annual per-participant grant limit for equity awards would significantly increase from 52 to 250,000 shares. While the company states this is necessary to attract and retain key personnel, this substantial potential dilution presents a negative signal, especially coming shortly after the company announced a $2.5 million share repurchase program on April 22, 2026, creating conflicting signals regarding capital allocation.